Ipca Laboratories Limited Announces Appointment of Kamal Kishore Seth as the Lead Independent Director
February 14, 2024 at 06:28 am EST
Share
Ipca Laboratories Limited announced the appointment of Mr. Kamal Kishore Seth as the `Lead Independent Director'. The Board has also re-constituted its following committees with effect from 14th February, 2024. The revised Board Committees will now comprise of the following Board Members: Audit Committee: Mr. Kamal Kishore Seth, Chairman of the Committee /Independent Director; Dr. Narendra Mairpady, Independent Director; Dr. (Ms.) Swati Patankar, Independent Director; Mr. Prashant Godha, Executive Director.
Nomination and Remuneration Committee: Dr. Narendra Mairpady, Chairman of the Committee /Independent Director; Mr. Kamal Kishore Seth, Independent Director; Dr. (Ms.) Manisha Premnath, Independent Director and Dr. (Ms.) Swati Patankar, Independent Director.
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIâs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Pharma Nigeria Ltd., Trophic Wellness Pvt. Ltd.